Nick had Campath as part of his regime in July, and also I think he had Tcell depleted donor cells.
In the literature we were given it said the Campath (Alemtuzumab) attaches itself onto a protein (CD52) on lymphocytes. This triggers the immune system to attack them.
It was given daily on days -8 til-4.
__________________
Gem, wife of Nick (57), dx CMML Dec 2007. Treated with 7 cycles Azacytidine. Transplant 30/6 RIC MUD.
|